Antibiotic resistance in bacteria is becoming an increasingly serious problem for the global healthcare system, leading to a reduction in the effectiveness of previously curable infections and even making some infections incurable. The World Health Organization (WHO) has listed it as one of the biggest threats to public healthcare in the 21st century. To address this issue, significant research efforts are being invested into discovery of new antimicrobial drugs.
Peptidoglycan is an important component of the bacterial cell wall, and its biosynthesis occurs in three regions: the cytoplasm, the cell membrane, and outside the cell. The MurA enzyme is present in the cytoplasm and initiates the pathway by catalyzing the first reaction. The majority of currently available antibiotics inhibit the peptidoglycan synthesis pathway, with their site of action in the later stages outside the cell. However, a few antibiotics act inside the cell, such as fosfomycin, which inhibits the activity of the MurA enzyme.
This master’s thesis focused on synthesizing two glucosamine derivatives based on molecular modeling and mimicking of the natural substrate. N-acetylglucosamine was utilized to correctly align functional groups and develop reversible inhibitors capable of penetrating the cell wall and membrane, reaching the bacteria’s interior where the MurA enzyme is located.
The primary purpose of the master’s thesis was to develop a synthetic route for preparing compounds that have acidic fragments attached to the hydroxyl group located at position 6. Firstly, all functional groups of N-acetylglucosamine, except for the hydroxyl group at position 6, were protected. Compound 11 was synthesized by directly introducing acetic acid onto the hydroxyl group using chloroacetic acid. For the synthesis of compound 9, the hydroxyl group was first activated by forming a tosylate, which was then utilized to form a derivative with dimethyl malonate. This derivative was finally hydrolyzed to yield carboxylic acid form. Enzyme testing confirmed that both compounds inhibited enzyme activity, with compound 9 having an IC50 value of 84 μM and compound 11 having an IC50 value of 14 µM.
|